STERIS Product — Revenue increased by 4.5% to $778.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.4%, from $718.30M to $778.90M. Over 3 years (FY 2022 to FY 2025), Product — Revenue shows an upward trend with a 4.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong market demand and successful sales execution for medical hardware and consumables, while a decrease may signal market saturation or competitive pressures.
This metric represents the total gross income generated from the sale of medical equipment, decontamination systems, and...
Comparable to 'Product Revenue' or 'Equipment Sales' reported by other medical technology and life sciences capital equipment manufacturers.
ste_segment_product_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $489.28M | $685.24M | $697.26M | $684.51M | $637.08M | $666.39M | $679.04M | $381.24M | $612.70M | $658.18M | $706.84M | $786.24M | $656.30M | $695.90M | $718.30M | $801.10M | $690.50M | $745.40M | $778.90M |
| QoQ Change | — | +40.1% | +1.8% | -1.8% | -6.9% | +4.6% | +1.9% | -43.9% | +60.7% | +7.4% | +7.4% | +11.2% | -16.5% | +6.0% | +3.2% | +11.5% | -13.8% | +8.0% | +4.5% |
| YoY Change | — | — | — | — | +30.2% | -2.7% | -2.6% | -44.3% | -3.8% | -1.2% | +4.1% | +106.2% | +7.1% | +5.7% | +1.6% | +1.9% | +5.2% | +7.1% | +8.4% |